CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Schenkein David P Director | Option exercise | +57,471 | $31.64 | $1.8M | 180,325 |
| 2024-02-27 | Schenkein David P Director | Sale | −57,471 | $34.89 | $2.0M | 122,854 |
| 2024-02-27 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −11,858 | 57,471 | ||
| 2024-02-27 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −57,471 | 0 | ||
| 2024-02-26 | Schenkein David P Director | Option exercise | +20,411 | $31.64 | $646K | 143,265 |
| 2024-02-26 | Schenkein David P Director | Sale | −20,411 | $33.19 | $677K | 122,854 |
| 2024-02-26 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −20,411 | 69,329 | ||
| 2024-02-23 | Schenkein David P Director | Option exercise | +47,731 | $31.64 | $1.5M | 170,585 |
| 2024-02-23 | Schenkein David P Director | Sale | −47,731 | $33.05 | $1.6M | 122,854 |
| 2024-02-23 | Schenkein David P Director | Option exercise · Stock option (right to buy) | −47,731 | 89,740 | ||
| 2024-02-20 | Washburn Theodore James Jr. Principal Accounting Officer | Sale | −504 | $26.63 | $13K | 2,741 |
| 2024-02-14 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −642 | $25.14 | $16K | 33,431 |
| 2024-02-14 | Burns James William Chief Legal Officer | Sale 10b5-1 | −545 | $25.14 | $14K | 31,666 |
| 2024-02-14 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −273 | $25.14 | $7K | 3,245 |
| 2024-02-12 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +2,162 | 34,073 | ||
| 2024-02-12 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −2,162 | 0 | ||
| 2024-02-12 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +1,833 | 32,211 | ||
| 2024-02-12 | Burns James William Chief Legal Officer | Option exercise · Restricted stock units 10b5-1 | −1,833 | 0 | ||
| 2024-02-12 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise 10b5-1 | +777 | 3,518 | ||
| 2024-02-12 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise · Restricted stock units 10b5-1 | −777 | 0 |
Page 24 of 48 · 941 trades